Happily Retired! Former Deputy Managing Editor, Energy & Commodities / Senior Editor, Health & Science at Bloomberg; Senior Editor, Health & Science at Newsday.
Status of science journalism worlwide:
@LuisaMassarani@SciDevNet 71% of science journalists think too few reporting on the *process* of science compared to the results
#SciYou2021#scicomm
Folks, we’re facing an urgent choice: do we keep an economy that serves the wealthiest and biggest corporations—or finally give middle class families a fair shot?
Our Build Back Better agenda is our moment to prove to the American people that their government works for them.
@thehill@RepDanCrenshaw Sadly, Republicans seem to care more about what’s happening at the border than the country’s failing infrastructure, or older Americans who can’t see or hear properly and have disabling dental problems or young families struggling to pay for child care. Politics anyone?
So let me get this straight: Republican legislators want to arm teachers to protect students from school shooters, but don't want teachers to wear masks to protect students from a deadly virus?
@phylogenomics Not so well done, The two words “vaccine skeptic” colors his views in carrying out any kind of real result from however many friends he employs. Studies need to be done by people who are looking for whatever the result may be, not those who have made up their minds ahead of time.
U.S. deaths passed the 500,000 mark. Global deaths related to Covid-19 have surpassed 2.46 million, with the U.S. leading all countries https://t.co/27Dgtbh3M9 via @business
An easier-to-spread variant of Covid-19 detected in the U.S. could increase the urgency for a speedier, more effective vaccine push https://t.co/4KUxCEbeBG via @bpolitics
The reopening of restaurants, gyms and hotels carries the highest risk of spreading Covid-19, according to one study https://t.co/iTGNC9tMvX via @business
The White House strategy of relying on vaccines and treatments rather than social distancing, masks and testing risks pushing the return of "normal" into 2023, a consultant warns https://t.co/FcH7PoDuB6 via @business
Two Covid-19 vaccines stalled by potential side effects have one key feature in common: both are based on adenoviruses, cold germs that researchers have used in experimental therapies for decades https://t.co/s5zGGUrtRt via @business
A company that performed Covid-19 tests for dozens of Massachusetts nursing homes is facing federal sanctions, including the possible loss of its license https://t.co/aK57mT4i04 via @business
Covid-19 cases are spiking in places like Iowa and South Dakota, signaling what may be a new phase as progress in one state is repeatedly offset by infections in others https://t.co/rk09YFv7Sz via @business
A 15-minute Covid test that will be priced at just $5 has been granted emergency authorization for use in the U.S. and could ease a major bottleneck https://t.co/nXc1aaZ5Tc via @business
Oops, says the FDA commissioner in clarifying his misstatements on an experimental therapy for Covid-19 patients, opening new fears about the FDA politicizing a vaccine. https://t.co/B7IfzLFl9F via @business